| Literature DB >> 31663643 |
E Forbat1, F Al-Niaimi2, F R Ali2.
Abstract
Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation, urticaria, angio-oedema and haemostasis, in addition to practical considerations of its use by dermatologists.Entities:
Year: 2019 PMID: 31663643 DOI: 10.1111/ced.14115
Source DB: PubMed Journal: Clin Exp Dermatol ISSN: 0307-6938 Impact factor: 3.470